makinezmoney
4 years ago
$WLYYF: Mega $18.5Billion Merger today in Health SPACE
TelaDOC & LIVONGO !!!!!!!!!
What space is WEll HEALTH in ?
This is a future buyout target... MARK MY WORDS !!!!!!!!!!
Now at $3.22
Adding another 10k around this price level
GO $WLYYF
Teladoc Health Inc. (TDOC) and Livongo Health Inc. (LVGO) said Wednesday they have agreed to merge in a deal valued at $18.5 billion to create a company that can serve a spectrum of health needs, using virtual care. Under the terms of the deal, Livongo shareholders will receive 0.592x shares of Teladoc plus $11.33 in cash per share owned. Teladoc shareholders will own abut 58% of the combined entity, while Livongo shareholders will own the remaining 42%. The combination "creates a global leader in consumer centered virtual care," the companies said in a joint statement. The new entity is expected to have pro forma revenue of about $1.3 billion for 2020, equal to pro forma growth of 85%. "Livongo is a world-class innovator we deeply admire and has demonstrated success improving the lives of people living with chronic conditions," Teladoc Chief Executive Jason Gorevic said in a statement. Together, we will further transform the healthcare experience from preventive care to the most complex cases, bringing 'whole person' health to consumers and greater value to our clients and shareholders as a result." The deal is expected to close in the fourth quarter. The combined company is expected to generate revenue synergies of $100 million by the end of the second year after the deal closes and to achieve $500 million on a run rate basis by 2025. Gorevic will be CEO of the combined company, and the board will comprise eight members of the Teladoc board and five members of the Livongo board. Teladoc shares fell 2.3% premarket, while Livongo was up 6.9%. -Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com (END) Dow Jones Newswires 08-05-20 0741ET Copyright (c) 2020 Dow Jones & Company, Inc.
makinezmoney
4 years ago
$WLYYF: Huge News today.... Cycura Services CyberSecurity
WELL Health Completes Acquisition of Cycura's Services Division and Forms New Cybersecurity Business Unit
8:00 AM ET 8/4/20 | Dow Jones
-- Cycura is a leader in providing top-tier cyber security services, whose
key principals have extensive experience in protecting patient health
data in the provincial Ministry of Health and acute care hospital
settings.
-- The acquisition is intended to elevate WELL's overall cybersecurity and
risk management program and provide WELL with another compelling
opportunity to build shareholder value through accretive and disciplined
capital allocation in the cybersecurity space.
-- In the past 12 months, Cycura's Services Division has generated revenues
of more than $1.7M with better than double digit EBITDA(1) profitability.
VANCOUVER, BC, Aug. 4, 2020 /CNW/ - WELL Health Technologies Corp. (TSX: WELL) (the "Company or "WELL"), is pleased to announce that it has completed its previously announced acquisition of the Services Division of Cycura Inc.(2) , a private Ontario corporation. The purchase price was approximately $2.55M, paid entirely with cash on hand, and subject to certain holdbacks, adjustments, and time-based payments. In the past 12 months, Cycura Inc.'s Services Division generated revenues exceeding $1.7M with EBITDA margins of over 10%. In addition, WELL announces it is retaining the Cycura brand name and the formation of a new business unit called Cycura Data Protection Corp. ("Cycura"). This new business unit will be led by Iain Paterson, who was previously the Managing Director of Cycura Inc. and will be the CEO of Cycura going forward. Iain will be supported closely by Melinda Coultar who was the Director of Consulting at Cycura Inc., and will now see an elevated role serving as Vice President of Services.
"We are very excited to welcome the talented and experienced team from Cycura led by Iain and Melinda and look forward to their leadership of the new Cybersecurity business unit at WELL," said Hamed Shahbazi, Chairman and CEO of WELL. "We believe this business unit will be a key leader and consolidator in the Canadian cybersecurity space with the overarching goal of helping keep private data including highly sensitive health data safe and secure"
Cycura provides industry leading cybersecurity services including penetration and vulnerability testing, security focused code reviews, incident response services, cybersecurity training, cybersecurity M&A advisory and technical due diligence services, and more. Cycura will operate as a wholly owned subsidiary of WELL, providing cyber security protection and patient data privacy solutions across all of the Company's business units including WELL Health Clinic Network, WELL EMR Group and WELL Digital Health Apps. In addition, Cycura will continue to serve its existing customers across a broad array of industries, including healthcare clients focusing on mental health, telemedicine, health insurance and benefits.
"We are excited to join WELL who shares our belief in the importance of improving cybersecurity resilience in the healthcare and health tech sector," said Iain Paterson, CEO of Cycura. "While Cycura will continue to serve our valued customers across a broad array of industries, we believe this is a tremendous opportunity for us to increase our market share in healthcare, while operating as a standalone business within WELL."
Mr. Paterson is a highly skilled information security leader and practitioner with more than 15 years of experience in enterprise wide information technology. Previously, Mr. Paterson was the Information Security Officer for Trillium Health Partners, one of the largest hospitals in Canada and worked under the office of the CISO at eHealth Ontario, which houses the healthcare records of 13M Ontario citizens and acts as the main data share for the majority of Ontario's hospitals. Iain holds an MBA with a focus in Leadership and Innovation, and has industry CISSP, CISM and SABSA certifications.
All key employees of Cycura are being retained under Mr. Paterson and Ms. Coultar's leadership whose focus and energy will ensure that WELL not only continues to provide the high quality service that clients have come to expect from the Cycura brand, but also expand product and service offerings so that Cycura can tackle a greater number of challenges and be a more valuable vendor to its client base.
Cycura was initially founded and supported by a diverse and successful group of investors and operators represented by Mr. Eitan Popper. WELL extends its appreciation to this group for their hard work in consummating the transaction.
"This is a beneficial transaction for both WELL and Cycura Inc. The importance of cybersecurity for practically any industry has become an indisputable reality. I believe that WELL will be able to leverage the capabilities of the Services Division of Cycura Inc., while at the same time enabling and supporting the Division's growth", stated Eitan Popper, Chairman of Cycura Inc.
1. EBITDA is a Non-GAAP measure. Earnings before interest, tax,
depreciation and amortization ("EBITDA") should not be construed as an
alternative to net income/loss determined in accordance with IFRS. EBITDA
does not have any standardized meanings under IFRS and therefore may not
be comparable to similar measures presented by other issuers. The
Company believes that EBITDA is a meaningful financial metric as it
measures cash generated from operations.
2. As a condition of the transaction, Cycura Inc. will change its name while
WELL will retain the Cycura name and brand and henceforth operate the
Cycura Services Division as Cycura Data Protection Corp.
WELL HEALTH TECHNOLOGIES CORP.
Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
About WELL Health Technologies Corp.
WELL is an omni-channel digital health company whose overarching objective is to empower doctors to provide the best and most advanced care possible while leveraging the latest technology and trends in digital health. As such, WELL owns and operates 20 primary healthcare medical clinics, is Canada's third largest Electronic Medical Records (EMR) supplier serving over 1,900 medical clinics, operates a leading national telehealth service and is a provider of digital health technology solutions. WELL is an acquisitive company that has completed twelve acquisitions and three equity investments. The Company is publicly traded on the Toronto Stock Exchange under the symbol "WELL". WELL was recognized as a TSX Venture 50 Company three years in a row in 2018, 2019 and 2020. To access the Company's telehealth service, visit: virtualclinics.ca and for corporate information, visit: www.WELL.company.
Notice Regarding Forward Looking Statements:
Certain statements in this news release related to the Company are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as "may", "should", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. Forward-looking statements in this news release include: statements regarding the closing of the Transaction, post-closing objectives of WELL for the Cycura brand, the expectation that the Transaction will be immediately accretive to WELL, and the anticipated margins thereof, the statement that the business unit will be a key leader and consolidator and the intention to retain all key employees of Cycura. There are numerous risks and uncertainties that could cause actual results and WELL's plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; and (ii) risks inherent in the cyber security industry in general and other factors beyond the control of the Company; (iii) risks related to the inability to close the Agreement for any reason; (iv) difficulties associated with the integration of the business; and (v) risks outlined in WELL's publicly filed periodic documents available on SEDAR. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.
Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE WELL Health Technologies Corp.
View original content to download multimedia: www.newswire.ca/en/releases/archive/August2020/04/c0176.html
/CONTACT:
Pardeep S. Sangha, Vice President Corporate Strategy and Investor Relations, investor@well.company, 604-572-6392
/Web site: well.company
Copyright CNW Group 2020
> Dow Jones Newswires
August 04, 2020 08:00 ET (12:00 GMT)
makinezmoney
5 years ago
$WLYYF: Almost 200k traded............ getting prepped for BUYOUT
https://www.cantechletter.com/2020/04/well-health-is-a-potential-take-out-target-stifel-gmp-says/
The growth here is undeniable.
Its going realllllllllllllllllllllllllly well !
GO $WLYYF
*****************************************************************
WELL Health Closes Strategic Investment in Insig Corporation and Rapidly Expands VirtualClinic Telehealth Program
7:30 AM ET 4/8/20 | Dow Jones
-- WELL Health has closed its previously announced share exchange
acquisition of approximately $3.94M in Insig shares and WELL's CEO Hamed
Shahbazi has joined Insig's board of directors.
-- This investment brings WELL's total investment in Insig to approximately
$5.94M, including the previously announced $2M secured, convertible
promissory note. Assuming the note will be fully converted, WELL becomes
the largest shareholder of Insig.
-- In addition, in accordance with its strategic alliance agreement with
Insig, WELL continues to rapidly grow and expand "VirtualClinic+", WELL's
own telehealth program to healthcare providers and patients across
Canada.
VANCOUVER, April 8, 2020 /CNW/ - WELL Health Technologies Corp. (TSX: WELL) ("WELL" or the "Company") announces, further to its news release dated March 26, 2020, that it has completed all components of its strategic investment in Insig Corporation ("Insig"), a market leader in the telehealth space in Canada.
WELL, Insig and certain shareholders of Insig entered into a share exchange agreement whereby the Company acquired a substantial minority equity position in Insig, comprised of approximately 2,625 Class A common shares of Insig ("Insig Shares"), in exchange for an aggregate consideration of 2,625,204 common shares in the capital of WELL at a deemed price of $1.50 per share, representing deemed consideration of approximately $3.94 million.
Including WELL's previously announced investment in Insig of a $2M secured, convertible promissory note (the "Convertible Note"), the Company's aggregate total investment in Insig is approximately $5.94M. WELL becomes the largest shareholder of Insig assuming full conversion of the Convertible Note.
Furthermore, WELL entered into a strategic alliance agreement with Insig which allowed WELL to commercialize and launch the Insig platform on a private label basis under the brand "VirtualClinic+". WELL's investment and partnership with Insig positions the Company as a leading provider of telehealth services in Canada. WELL's CEO Hamed Shahbazi has also joined Insig's board of directors and will help support Insig's efforts to grow and meet the rapidly expanding need for telehealth services amongst Canadian doctors and patients.
"WELL has seen tremendous interest and activity in its VirtualClinic+ telehealth service, which now includes hundreds of healthcare practitioners delivering thousands of consultations per week," said Hamed Shahbazi, Chairman and & CEO of WELL. "We are thrilled to be partnering with the Insig team to deliver highly accessible quality healthcare for Canadians at this critical time. Also, I am personally looking forward to serving on the Insig board and furthering the success of what we believe to be, the most exciting telehealth platform in the country."
"We are excited to have WELL as both an investor and a strategic partner, " said Matthew Mazzuca, CEO of Insig. "WELL's leadership and network in the healthcare industry is a great fit with our technology platform. Working together we can deliver a telehealth solution that meets the needs of Canadian doctors while improving patient access to healthcare."
To access WELL's VirtualClinic+ telehealth service, visit virtualclinics.ca.
WELL HEALTH TECHNOLOGIES CORP.
Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
About WELL Health Technologies Corp.
WELL is a unique company that operates Primary Healthcare Facilities, is the third largest digital Electronic Medical Records (EMR) supplier in Canada and is a provider of telehealth services. WELL owns and operates 21 healthcare clinics, provides digital EMR software and services to 1,446 clinics across Canada and is a majority owner of SleepWorks Medical. WELL's overarching objective is to empower doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health. WELL is an acquisitive company that has completed nine acquisitions and two equity investments. WELL is publicly traded on the Toronto Stock Exchange under the symbol "WELL-T". WELL was recognized as a TSX Venture 50 Company three years in a row in 2018, 2019 and 2020.
About Insig Corporation
Insig is a private Canadian company engaged in developing telemedicine platforms, and clinical automation software. Insig has grown to serve hundreds of physicians and medical practitioners across the country, with over 100,000 patients having used the platform. Insig's goal is to remove the administrative burden in medical practice so doctors can focus on what they do best, practice medicine.
Notice Regarding Forward Looking Statements:
Certain statements in this news release related to the Company are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as "may", "should", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding: the assumption that the Convertible Note will be fully converted, and WELL will maintain its position as Insig's largest shareholder; the ability of the strategic alliance and Hamed Shahbazi's appointment to Insig's board of directors to support Insig's efforts to grow and meet the rapidly expanding need for telehealth services amongst Canadian doctors and patients; the ability of the Company and Insig to work together to continue to rapidly ramp up the availability of telehealth services to all Canadians to meet the increasing demand for healthcare services as a result of COVID-19; and the assumption that the strategic partnership between WELL and Insig can deliver a telehealth solution that meets the needs of Canadian doctors while improving patient access to healthcare. There are numerous risks and uncertainties that could cause actual results and WELL's plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; and (ii) risks inherent in the primary healthcare sector in general and other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.
Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE WELL Health Technologies Corp.
View original content to download multimedia: www.newswire.ca/en/releases/archive/April2020/08/c8022.html
/CONTACT:
Pardeep S. Sangha, VP Corporate Strategy and Investor Relations, WELL Health Technologies Corp., pardeep.sangha@well.company, www.WELL.company, 604-628-7266; David Del Balso, President, Insig Corporation, david@insighealth.com, www.insighealth.com
/Web site: well.company
Copyright CNW Group 2020
> Dow Jones Newswires
April 08, 2020 07:30 ET (11:30 GMT)
makinezmoney
5 years ago
$WLYYF: More M&A and Growth in the Cards
"SIGNIFICANT UPSIDE"
https://www.cantechletter.com/2019/09/well-health-is-set-for-more-ma-growth-says-pi-financial/
GO $WLYYF
********************************************************************
Well Health is set for more M&A growth, says PI Financial
SEPTEMBER 17, 2019 BY JAYSON MACLEAN
WELL Health Technologies GMPIt’s a matter of when not if Well Health Technologies (Well Health Stock Quote, Chart, News TSXV:WELL) will be making more moves on the M&A front, says PI Financial analyst David Kwan.
In a corporate update on Monday Kwan reiterated his “Buy” rating and $1.80 per share target price for WELL. Kwan says he marketed Chairman and CEO Hamed Shahbazi last week, detailing the company’s disciplined focus on capital allocation.
“The M&A pipeline remains top of mind for investors,” says Kwan. “On that front, WELL has close to a dozen targets at various stages of the LOI process (split ~50/50 between chains of clinics and EMR/software companies) while it has a modestly larger number of additional targets where they are at an earlier stage of the M&A process.”
“WELL is focused on expanding its clinic footprint in Ontario but is also looking at growing its presence in B.C., while on the digital services front, WELL is looking to further consolidate the OSCAR market while adding complementary technologies like telemedicine,” said Kwan, who noted that to date, every LOI that WELL has signed has resulted in an acquisition, suggesting that we should expect more acquisitions in the quarters and years to come.
Kwan evaluates the marketing event as slightly positive for the stock and adds that WELL is now evaluating the possibility of up-listing to the TSX, which would open up the company to a larger set of potential investors and potentially bolster the stock’s valuation.
Well Health’s share price took off in early July on press coverage of the stock, taking it from the $0.90 range to where it currently resides in the $1.60 range. Year-to-date, WELL is up 269 per cent.
Kwan’s $1.80 target is based on a 4.5x multiple of his fiscal 2020 revenue estimate for WELL’s digital services business and a 3.5x multiple of his fiscal 2020 revenue estimate for WELL’s clinic business. The target represents a projected 12-month return of 9.1 per cent at the time of publication.
Kwan says WELL has the war chest available to keep the acquisitions coming.
WELL Health stock could have “significant” upside…
“With a cashed up balance sheet and the Company expected to turn cash flow positive soon, we note that WELL has plenty of additional capital to deploy for acquisitions that could provide (significant) upside to our forecasts,” he writes.
Going forward, the analyst thinks WELL will generate fiscal 2019 revenue and adjusted EBITDA of $31.4 million and negative $1.6 million, respectively, and fiscal 2020 revenue and EBITDA of $56.1 million and $2.7 million, respectively.
Last month, Vancouver-based Well Health released its second quarter 2019 financials, featuring revenue of $7.4 million, a 258-per-cent increase year-over-year and an adjusted EBITDA loss of $287,000.
Over the quarter, WELL completed its acquisition of OCSARprn – Treatment Solutions, while subsequent to the quarter, the company completed the acquisition of Kela Atlantic dba KAI Innovations.
“Q2 was an excellent quarter for us which demonstrated continued strong clinical revenue growth and increasing gross margin from our SaaS based EMR service,” said Hamed Shahbazi, Chairman and CEO of WELL. “In addition, the recently completed acquisition of KAI Innovations has been a very strong fit with our prior EMR related acquisitions and has spurred new growth and expanded capabilities in our EMR business.”
Disclaimer: Nick Waddell and Jayson MacLean from Cantech Letter own shares of WELL Health and the company is an annual sponsor of this publication.
makinezmoney
5 years ago
$WLYYF: Huge Acquisition... Kai Innovations for $10.5MIllion
Running now at $1.31
No Limit on the ASK..... Sky HIGH clear on the L2
GO $WLLYF
*****************************************************
Press Release: WELL Health Completes Acquisition of Kai Innovations, Canada's largest provider of OSCAR EMR Services
8:05 AM ET 7/2/19 | Dow Jones
WELL Health Completes Acquisition of Kai Innovations, Canada's largest provider of OSCAR EMR Services
Canada NewsWire
VANCOUVER, July 2, 2019
-- Acquisition of KAI has significantly expanded WELL's digital health
portfolio to now provide Electronic Medical Records ("EMR") SaaS1
services to approximately 852 medical clinics across Canada, supporting
more than 4000 registered doctors & practitioners and over 15 million
patients2
-- KAI's award winning founders, Arjun Kumar and Sara Bond have joined
WELL's technology management team and will help drive the digital health
portfolio of the company.
-- Acquisition of KAI is immediately financially accretive to WELL and is
expected to improve WELL's gross margin and operating margin
VANCOUVER, July 2, 2019 /CNW/ - WELL Health Technologies Corp. (TSX.V: WELL) (the "Company" or "WELL"), a company focused on consolidating and modernizing clinical and digital assets within the primary healthcare sector, is pleased to announce the closing of its previously announced acquisition (the "Acquisition") of Kela Atlantic Inc. dba KAI Innovations ("KAI"). KAI provides SaaS (Software as a Service) based Electronic Medical Records ("EMR") services to approximately 562 clinics in Ontario, supporting approximately 2,100 registered doctors and practitioners.
"KAI is highly accretive to WELL on both a strategic and financial basis" said Hamed Shahbazi, Chairman and CEO of WELL, "With this acquisition, WELL is now the largest provider of OSCAR(3) EMR services in Canada supporting approximately 852 clinics, which to our understanding positions the Company as the third largest EMR services provider in Canada. We're very pleased to welcome the talented KAI team to the WELL family."
KAI, the recipient of Canadian Business Magazine's 2015 Startup of the Year, has the third largest EMR user base in Ontario and is the largest provider of OSCAR EMR services to healthcare clinics in Canada.
"We're very pleased to be joining the WELL team and helping drive the next generation of digital health innovation in Canada" said Arjun Kumar, co-Founder and CEO of KAI Innovations. "We're also looking forward to continuing to support the OSCAR community and ensuring that this community continues to grow and thrive as the industry changes with WELL's support".
The details of the Acquisition were previously announced in the Company's news release dated May 30, 2019. Pursuant to the share purchase agreement dated May 30(th) , 2019 and amended on June 28(th) , 2019, the aggregate purchase price for KAI was approximately $10,750,000, consisting of the following: (i) $6,000,000 paid in cash upon closing of the Acquisition; (ii) $2,000,000 paid in the capital of WELL shares at a price of approximately $0.705 per share; and (iii) cash payments of $2,750,000 to be paid in the first year after closing. In addition, WELL will pay a conditional earn-out based on overall operating performance of up to $7,000,000.
The consideration shares issued by WELL are subject to a restricted period of four months and one day. There were no finder's fees paid in connection with the Transaction.
1. SaaS is a acronym for "Software as a Service"
2. Patient count is based on total number of patient profiles and does not
exclude duplicate patient records, inactive or deceased patients.
3. OSCAR, an acronym for "Open Source Clinical Application Resource", is a
leading open source based EMR software that was developed by McMaster
University.
WELL HEALTH TECHNOLOGIES CORP.
Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
About WELL
WELL is a unique company that operates Primary Healthcare Facilities as well as a significant EMR or Electronic Medical Records business that provides SaaS EMR services to more than 4000 doctors across Canada. WELL's overarching objective is to empower doctors to provide the best and most advanced care possible leveraging the latest trends in digital health. In the last 12 months, WELL physicians served approximately 600,000 patient visits through its network of 19 medical clinics. WELL is publicly traded on the TSX Venture Exchange under the symbol WELL.V. WELL was recognized as a TSX Venture 50 Company in 2018 and 2019.
Forward-Looking Statements
This news release may contain "forward-looking statements" within the meaning of applicable Canadian securities laws, including, without limitation: the ability of WELL to provide and continue providing services to the anticipated number of clinics, practitioners and patients; and the belief that such acquisitions will position WELL as one of the leading EMR providers in Canada. Forward looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties, and contingencies. These statements generally can be identified by the use of forward-looking words such as "may", "should", "will", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause future results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. WELL's statements expressed or implied by these forward-looking statements are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL's control, and undue reliance should not be placed on such statements. Forward-looking statements are qualified in their entirety by the inherent risks and uncertainties surrounding the Transaction, including: that WELL's assumptions in making forward-looking statements may prove to be incorrect; adverse market conditions; risks inherent in the primary healthcare sector in general; that future results may vary from historical results; and that market competition may affect the outcome of the business, results and financial condition of WELL. Except as required by securities law, WELL does not assume any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release
SOURCE WELL Health Technologies Corp.
View original content: www.newswire.ca/en/releases/archive/July2019/02/c8503.html
/CONTACT:
Pardeep S. Sangha, VP Corporate Strategy and Investor Relations, investor@well.company, www.WELL.company, 604-628-7266
/Web site: www.well.company
Copyright CNW Group 2019
> Dow Jones Newswires
July 02, 2019 08:05 ET (12:05 GMT)
Level up your trading with our powerful tools and real-time insights all in one place.
Ask ADVFN Intelligence (AI)
Renee
3 years ago
nowwhat2
4 years ago
Hot Features
Premium
